These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 11907506)
41. Surgical treatment of basal cell carcinomas using standard postoperative histological assessment. Walker P; Hill D Australas J Dermatol; 2006 Feb; 47(1):1-12. PubMed ID: 16405477 [TBL] [Abstract][Full Text] [Related]
42. The biologic behavior of basal cell carcinoma: analysis of recurrence in excised basal cell carcinoma: Part II. Hauben DJ; Zirkin H; Mahler D; Sacks M Plast Reconstr Surg; 1982 Jan; 69(1):110-6. PubMed ID: 7053498 [TBL] [Abstract][Full Text] [Related]
43. [Histologic risk factors of basal cell carcinoma of the face, about 184 cases]. Wavreille O; Martin De Lassalle E; Wavreille G; Mortier L; Martinot Duquennoy V Ann Chir Plast Esthet; 2012 Dec; 57(6):542-8. PubMed ID: 22534511 [TBL] [Abstract][Full Text] [Related]
44. Cutaneous carcinoma with mixed histology: a potential etiology for skin cancer recurrence and an indication for Mohs microscopically controlled surgical excision. Cohen PR; Schulze KE; Nelson BR South Med J; 2005 Jul; 98(7):740-7. PubMed ID: 16108247 [TBL] [Abstract][Full Text] [Related]
45. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases. Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746 [TBL] [Abstract][Full Text] [Related]
46. Accuracy of serial transverse cross-sections in detecting residual basal cell carcinoma at the surgical margins of an elliptical excision specimen. Kimyai-Asadi A; Goldberg LH; Jih MH J Am Acad Dermatol; 2005 Sep; 53(3):469-74. PubMed ID: 16112355 [TBL] [Abstract][Full Text] [Related]
47. Characteristics of incompletely excised basal cell carcinomas of the skin. Rippey JJ; Rippey E Med J Aust; 1997 Jun; 166(11):581-3. PubMed ID: 9201177 [TBL] [Abstract][Full Text] [Related]
49. Incidence and factors associated with recurrence after incomplete excision of basal cell carcinomas: a study of 90 cases. Santiago F; Serra D; Vieira R; Figueiredo A J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1421-4. PubMed ID: 20384689 [TBL] [Abstract][Full Text] [Related]
50. Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases. Farhi D; Dupin N; Palangié A; Carlotti A; Avril MF Dermatol Surg; 2007 Oct; 33(10):1207-14. PubMed ID: 17903153 [TBL] [Abstract][Full Text] [Related]
51. Clinicopathological features and histological tumor residues in re-excision specimens of incompletely resected basal cell carcinomas. Lütgerath C; Weiß C; Böer-Auer A J Dtsch Dermatol Ges; 2022 Nov; 20(11):1476-1483. PubMed ID: 36259274 [TBL] [Abstract][Full Text] [Related]
52. Laboratory errors leading to nonmelanoma skin cancer recurrence after Mohs micrographic surgery. Zabielinski M; Leithauser L; Godsey T; Gloster HM Dermatol Surg; 2015 Aug; 41(8):913-6. PubMed ID: 26218725 [TBL] [Abstract][Full Text] [Related]
53. Recurrence rate of basal cell carcinoma with positive histopathological margins and related risk factors. Lara F; Santamaría JR; Garbers LE An Bras Dermatol; 2017; 92(1):58-62. PubMed ID: 28225958 [TBL] [Abstract][Full Text] [Related]
54. What to do with basal cell carcinoma leftovers. Dzubow LM J Am Acad Dermatol; 2002 Apr; 46(4):639. PubMed ID: 11907526 [No Abstract] [Full Text] [Related]
55. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Smeets NW; Krekels GA; Ostertag JU; Essers BA; Dirksen CD; Nieman FH; Neumann HA Lancet; 2004 Nov 13-19; 364(9447):1766-72. PubMed ID: 15541449 [TBL] [Abstract][Full Text] [Related]
56. Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma. Delgado Jiménez Y; Camarero-Mulas C; Sanmartín-Jiménez O; Garcés JR; Rodríguez-Prieto MÃ; Alonso-Alonso T; Miñano Medrano R; López-Estebaranz JL; de Eusebio Murillo E; Redondo P; Ciudad-Blanco C; Toll A; Artola Igarza JL; Allende Markixana I; Suarez Fernández R; Alfaro Rubio A; Alonso Pacheco ML; Vázquez-Veiga H; de la Cueva Dobao P; Ruiz-Salas V; Vilarrasa E; Barchino L; Morales-Gordillo V; Ocerin-Guerra I; Navarro Tejedor R; Hueso L; Mayor Arenal M; Seoane-Pose MJ; Cano-Martinez N; Garcia-Doval I; Descalzo MA; Int J Dermatol; 2018 Nov; 57(11):1375-1381. PubMed ID: 30246444 [TBL] [Abstract][Full Text] [Related]
57. Positive margins in basal cell carcinoma: relationship to clinical features and recurrence risk. A retrospective study of 248 patients. Nagore E; Grau C; Molinero J; Fortea JM J Eur Acad Dermatol Venereol; 2003 Mar; 17(2):167-70. PubMed ID: 12705745 [TBL] [Abstract][Full Text] [Related]
58. 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma. Paoli J; Daryoni S; Wennberg AM; Mölne L; Gillstedt M; Miocic M; Stenquist B Acta Derm Venereol; 2011 Oct; 91(6):689-93. PubMed ID: 21681360 [TBL] [Abstract][Full Text] [Related]
59. Relapses and recurrences of basal cell face carcinomas. Ocanha JP; Dias JT; Miot HA; Stolf HO; Marques ME; Abbade LP An Bras Dermatol; 2011; 86(2):386-8. PubMed ID: 21603832 [TBL] [Abstract][Full Text] [Related]
60. Recurrent basal cell carcinoma. A review concerning the incidence, behavior, and management of recurrent basal cell carcinoma, with emphasis on the incompletely excised lesion. Koplin L; Zarem HA Plast Reconstr Surg; 1980 May; 65(5):656-64. PubMed ID: 7367506 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]